Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-25-004435
Filing Date
2025-07-11
Accepted
2025-07-11 16:35:42
Documents
2
Period of Report
2025-07-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1621
2 EXHIBIT 24 exh_24.htm EX-24 8907
  Complete submission text file 0001171843-25-004435.txt   11966
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703
Business Address
Ghias Babar (Reporting) CIK: 0002076862 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23186 | Film No.: 251119377